nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CYP2B6—Thiotepa—sarcoma	0.123	0.212	CbGbCtD
Nicardipine—CYP2E1—Dacarbazine—sarcoma	0.0692	0.119	CbGbCtD
Nicardipine—CYP2E1—Mitoxantrone—sarcoma	0.0537	0.0923	CbGbCtD
Nicardipine—CYP3A4—Thiotepa—sarcoma	0.0378	0.0651	CbGbCtD
Nicardipine—CYP2E1—Etoposide—sarcoma	0.0338	0.0582	CbGbCtD
Nicardipine—ABCB1—Dactinomycin—sarcoma	0.0303	0.0522	CbGbCtD
Nicardipine—CYP3A5—Vincristine—sarcoma	0.0287	0.0494	CbGbCtD
Nicardipine—ABCB1—Mitoxantrone—sarcoma	0.0271	0.0467	CbGbCtD
Nicardipine—CYP3A5—Etoposide—sarcoma	0.0263	0.0452	CbGbCtD
Nicardipine—CYP2C8—Etoposide—sarcoma	0.0253	0.0435	CbGbCtD
Nicardipine—CYP2B6—Doxorubicin—sarcoma	0.0228	0.0392	CbGbCtD
Nicardipine—ABCB1—Vincristine—sarcoma	0.0187	0.0321	CbGbCtD
Nicardipine—ABCB1—Etoposide—sarcoma	0.0171	0.0294	CbGbCtD
Nicardipine—CYP3A4—Mitoxantrone—sarcoma	0.0163	0.028	CbGbCtD
Nicardipine—ABCB1—Doxorubicin—sarcoma	0.0117	0.0201	CbGbCtD
Nicardipine—CYP3A4—Vincristine—sarcoma	0.0112	0.0192	CbGbCtD
Nicardipine—CYP2D6—Doxorubicin—sarcoma	0.011	0.0189	CbGbCtD
Nicardipine—CYP3A4—Etoposide—sarcoma	0.0103	0.0176	CbGbCtD
Nicardipine—CYP3A4—Doxorubicin—sarcoma	0.00699	0.012	CbGbCtD
Nicardipine—CHRM3—muscle of abdomen—sarcoma	0.00552	0.0714	CbGeAlD
Nicardipine—CACNA2D1—mammary gland—sarcoma	0.00204	0.0264	CbGeAlD
Nicardipine—PDE1A—smooth muscle tissue—sarcoma	0.00158	0.0205	CbGeAlD
Nicardipine—CALM3—mammary gland—sarcoma	0.00147	0.019	CbGeAlD
Nicardipine—CALM2—endothelium—sarcoma	0.00143	0.0185	CbGeAlD
Nicardipine—CALM1—endothelium—sarcoma	0.00143	0.0184	CbGeAlD
Nicardipine—PDE1A—uterus—sarcoma	0.00136	0.0176	CbGeAlD
Nicardipine—CACNA1C—myometrium—sarcoma	0.00125	0.0161	CbGeAlD
Nicardipine—PDE1A—tendon—sarcoma	0.00119	0.0154	CbGeAlD
Nicardipine—PDE1B—testis—sarcoma	0.00118	0.0152	CbGeAlD
Nicardipine—CALM1—mammary gland—sarcoma	0.00115	0.0149	CbGeAlD
Nicardipine—CHRM5—skin of body—sarcoma	0.00112	0.0145	CbGeAlD
Nicardipine—CALM3—myometrium—sarcoma	0.00104	0.0135	CbGeAlD
Nicardipine—CACNA1C—connective tissue—sarcoma	0.00103	0.0133	CbGeAlD
Nicardipine—CACNB2—cardiac atrium—sarcoma	0.00101	0.013	CbGeAlD
Nicardipine—PDE1A—testis—sarcoma	0.000986	0.0127	CbGeAlD
Nicardipine—CYP2C8—mammary gland—sarcoma	0.000958	0.0124	CbGeAlD
Nicardipine—CALM3—seminal vesicle—sarcoma	0.000943	0.0122	CbGeAlD
Nicardipine—CACNA1C—smooth muscle tissue—sarcoma	0.000943	0.0122	CbGeAlD
Nicardipine—PDE1A—liver—sarcoma	0.000932	0.012	CbGeAlD
Nicardipine—CHRM4—testis—sarcoma	0.000902	0.0117	CbGeAlD
Nicardipine—CACNA1D—cardiac atrium—sarcoma	0.00088	0.0114	CbGeAlD
Nicardipine—CACNB2—tendon—sarcoma	0.000878	0.0113	CbGeAlD
Nicardipine—PDE1B—lymph node—sarcoma	0.000853	0.011	CbGeAlD
Nicardipine—CYP2C9—mammary gland—sarcoma	0.000851	0.011	CbGeAlD
Nicardipine—CACNA2D1—tendon—sarcoma	0.000824	0.0107	CbGeAlD
Nicardipine—CALM2—myometrium—sarcoma	0.00082	0.0106	CbGeAlD
Nicardipine—CALM1—myometrium—sarcoma	0.000816	0.0105	CbGeAlD
Nicardipine—CACNA1C—cardiac atrium—sarcoma	0.000813	0.0105	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—sarcoma	0.000799	0.0103	CbGeAlD
Nicardipine—CALM3—smooth muscle tissue—sarcoma	0.00079	0.0102	CbGeAlD
Nicardipine—CALM2—embryo—sarcoma	0.000789	0.0102	CbGeAlD
Nicardipine—CALM1—embryo—sarcoma	0.000785	0.0101	CbGeAlD
Nicardipine—CALM2—seminal vesicle—sarcoma	0.000741	0.00957	CbGeAlD
Nicardipine—CACNB2—testis—sarcoma	0.000727	0.0094	CbGeAlD
Nicardipine—PDE1A—lymph node—sarcoma	0.000715	0.00924	CbGeAlD
Nicardipine—CALM2—hematopoietic system—sarcoma	0.000704	0.0091	CbGeAlD
Nicardipine—CALM1—hematopoietic system—sarcoma	0.000701	0.00906	CbGeAlD
Nicardipine—CACNB2—liver—sarcoma	0.000687	0.00888	CbGeAlD
Nicardipine—CACNA2D1—testis—sarcoma	0.000683	0.00882	CbGeAlD
Nicardipine—CALM3—cardiac atrium—sarcoma	0.000681	0.0088	CbGeAlD
Nicardipine—CALM2—connective tissue—sarcoma	0.000678	0.00876	CbGeAlD
Nicardipine—CALM3—uterus—sarcoma	0.000677	0.00875	CbGeAlD
Nicardipine—CALM1—connective tissue—sarcoma	0.000675	0.00872	CbGeAlD
Nicardipine—CYP2C19—hematopoietic system—sarcoma	0.000668	0.00864	CbGeAlD
Nicardipine—ADRA1A—hematopoietic system—sarcoma	0.00066	0.00853	CbGeAlD
Nicardipine—CACNA2D1—liver—sarcoma	0.000645	0.00834	CbGeAlD
Nicardipine—CACNA1D—testis—sarcoma	0.000635	0.00821	CbGeAlD
Nicardipine—CHRM3—smooth muscle tissue—sarcoma	0.000633	0.00819	CbGeAlD
Nicardipine—CALM2—smooth muscle tissue—sarcoma	0.00062	0.00801	CbGeAlD
Nicardipine—CALM1—smooth muscle tissue—sarcoma	0.000617	0.00798	CbGeAlD
Nicardipine—CALM2—skin of body—sarcoma	0.000612	0.00791	CbGeAlD
Nicardipine—CALM1—skin of body—sarcoma	0.000609	0.00787	CbGeAlD
Nicardipine—CACNA1D—liver—sarcoma	0.000601	0.00776	CbGeAlD
Nicardipine—CALM3—tendon—sarcoma	0.000593	0.00767	CbGeAlD
Nicardipine—CACNA1C—testis—sarcoma	0.000586	0.00758	CbGeAlD
Nicardipine—CYP2C8—hematopoietic system—sarcoma	0.000583	0.00754	CbGeAlD
Nicardipine—CALM3—bone marrow—sarcoma	0.000575	0.00743	CbGeAlD
Nicardipine—CALM2—cardiac atrium—sarcoma	0.000535	0.00691	CbGeAlD
Nicardipine—CALM1—cardiac atrium—sarcoma	0.000532	0.00688	CbGeAlD
Nicardipine—CALM2—uterus—sarcoma	0.000532	0.00687	CbGeAlD
Nicardipine—CALM1—uterus—sarcoma	0.000529	0.00684	CbGeAlD
Nicardipine—CACNB2—lymph node—sarcoma	0.000527	0.00681	CbGeAlD
Nicardipine—CYP3A5—hematopoietic system—sarcoma	0.000527	0.00681	CbGeAlD
Nicardipine—CYP2B6—hematopoietic system—sarcoma	0.000523	0.00676	CbGeAlD
Nicardipine—CYP2C9—hematopoietic system—sarcoma	0.000518	0.0067	CbGeAlD
Nicardipine—CYP2E1—seminal vesicle—sarcoma	0.000517	0.00668	CbGeAlD
Nicardipine—CALM2—lymphoid tissue—sarcoma	0.000496	0.00641	CbGeAlD
Nicardipine—CACNA2D1—lymph node—sarcoma	0.000495	0.0064	CbGeAlD
Nicardipine—CALM1—lymphoid tissue—sarcoma	0.000493	0.00638	CbGeAlD
Nicardipine—CALM3—testis—sarcoma	0.000491	0.00635	CbGeAlD
Nicardipine—CYP2E1—hematopoietic system—sarcoma	0.000491	0.00635	CbGeAlD
Nicardipine—Thrombocytopenia—Dactinomycin—sarcoma	0.000467	0.0037	CcSEcCtD
Nicardipine—CALM2—tendon—sarcoma	0.000466	0.00602	CbGeAlD
Nicardipine—ADRA1A—lymphoid tissue—sarcoma	0.000465	0.00601	CbGeAlD
Nicardipine—CALM3—liver—sarcoma	0.000464	0.006	CbGeAlD
Nicardipine—CALM1—tendon—sarcoma	0.000464	0.00599	CbGeAlD
Nicardipine—CACNA1D—lymph node—sarcoma	0.000461	0.00595	CbGeAlD
Nicardipine—Malaise—Mitoxantrone—sarcoma	0.000459	0.00363	CcSEcCtD
Nicardipine—CYP2B6—skin of body—sarcoma	0.000455	0.00588	CbGeAlD
Nicardipine—CALM2—bone marrow—sarcoma	0.000451	0.00583	CbGeAlD
Nicardipine—Flushing—Etoposide—sarcoma	0.000451	0.00357	CcSEcCtD
Nicardipine—Hypertension—Vincristine—sarcoma	0.000451	0.00357	CcSEcCtD
Nicardipine—CALM1—bone marrow—sarcoma	0.000449	0.00581	CbGeAlD
Nicardipine—Myalgia—Vincristine—sarcoma	0.000445	0.00352	CcSEcCtD
Nicardipine—Hypertonia—Doxorubicin—sarcoma	0.00044	0.00348	CcSEcCtD
Nicardipine—Hypertension—Mitoxantrone—sarcoma	0.000439	0.00348	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000438	0.00347	CcSEcCtD
Nicardipine—Abnormal vision—Doxorubicin—sarcoma	0.000438	0.00347	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000435	0.00344	CcSEcCtD
Nicardipine—Chest pain—Mitoxantrone—sarcoma	0.000433	0.00343	CcSEcCtD
Nicardipine—Myalgia—Mitoxantrone—sarcoma	0.000433	0.00343	CcSEcCtD
Nicardipine—Arthralgia—Mitoxantrone—sarcoma	0.000433	0.00343	CcSEcCtD
Nicardipine—Paraesthesia—Thiotepa—sarcoma	0.000432	0.00342	CcSEcCtD
Nicardipine—Anxiety—Mitoxantrone—sarcoma	0.000432	0.00342	CcSEcCtD
Nicardipine—Discomfort—Mitoxantrone—sarcoma	0.000428	0.00339	CcSEcCtD
Nicardipine—Somnolence—Thiotepa—sarcoma	0.000427	0.00338	CcSEcCtD
Nicardipine—Oedema—Vincristine—sarcoma	0.000426	0.00337	CcSEcCtD
Nicardipine—CACNA1C—lymph node—sarcoma	0.000425	0.0055	CbGeAlD
Nicardipine—Infection—Vincristine—sarcoma	0.000424	0.00335	CcSEcCtD
Nicardipine—Dyspepsia—Thiotepa—sarcoma	0.000423	0.00335	CcSEcCtD
Nicardipine—Hot flush—Epirubicin—sarcoma	0.000421	0.00333	CcSEcCtD
Nicardipine—Confusional state—Mitoxantrone—sarcoma	0.000419	0.00331	CcSEcCtD
Nicardipine—Menopausal symptoms—Epirubicin—sarcoma	0.000417	0.0033	CcSEcCtD
Nicardipine—Thrombocytopenia—Vincristine—sarcoma	0.000417	0.0033	CcSEcCtD
Nicardipine—Oedema—Mitoxantrone—sarcoma	0.000415	0.00329	CcSEcCtD
Nicardipine—Infection—Mitoxantrone—sarcoma	0.000413	0.00326	CcSEcCtD
Nicardipine—Hyperhidrosis—Vincristine—sarcoma	0.000412	0.00326	CcSEcCtD
Nicardipine—Pain—Thiotepa—sarcoma	0.000411	0.00325	CcSEcCtD
Nicardipine—Constipation—Thiotepa—sarcoma	0.000411	0.00325	CcSEcCtD
Nicardipine—Shock—Mitoxantrone—sarcoma	0.000409	0.00323	CcSEcCtD
Nicardipine—Pain—Dactinomycin—sarcoma	0.000408	0.00323	CcSEcCtD
Nicardipine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000407	0.00322	CcSEcCtD
Nicardipine—Tachycardia—Mitoxantrone—sarcoma	0.000405	0.00321	CcSEcCtD
Nicardipine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000401	0.00318	CcSEcCtD
Nicardipine—Hypotension—Vincristine—sarcoma	0.000398	0.00315	CcSEcCtD
Nicardipine—Feeling abnormal—Thiotepa—sarcoma	0.000396	0.00314	CcSEcCtD
Nicardipine—CYP3A4—hematopoietic system—sarcoma	0.000395	0.00511	CbGeAlD
Nicardipine—CHRM3—testis—sarcoma	0.000394	0.00509	CbGeAlD
Nicardipine—Feeling abnormal—Dactinomycin—sarcoma	0.000393	0.00311	CcSEcCtD
Nicardipine—Gastrointestinal pain—Thiotepa—sarcoma	0.000393	0.00311	CcSEcCtD
Nicardipine—Ill-defined disorder—Etoposide—sarcoma	0.000393	0.00311	CcSEcCtD
Nicardipine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00039	0.00309	CcSEcCtD
Nicardipine—Hot flush—Doxorubicin—sarcoma	0.00039	0.00308	CcSEcCtD
Nicardipine—CYP2D6—hematopoietic system—sarcoma	0.000389	0.00503	CbGeAlD
Nicardipine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000388	0.00307	CcSEcCtD
Nicardipine—Hypotension—Mitoxantrone—sarcoma	0.000388	0.00307	CcSEcCtD
Nicardipine—Menopausal symptoms—Doxorubicin—sarcoma	0.000386	0.00306	CcSEcCtD
Nicardipine—CALM2—testis—sarcoma	0.000386	0.00499	CbGeAlD
Nicardipine—Insomnia—Vincristine—sarcoma	0.000386	0.00305	CcSEcCtD
Nicardipine—CALM1—testis—sarcoma	0.000384	0.00496	CbGeAlD
Nicardipine—Paraesthesia—Vincristine—sarcoma	0.000383	0.00303	CcSEcCtD
Nicardipine—Malaise—Etoposide—sarcoma	0.000382	0.00302	CcSEcCtD
Nicardipine—Face oedema—Epirubicin—sarcoma	0.00038	0.00301	CcSEcCtD
Nicardipine—Vertigo—Etoposide—sarcoma	0.00038	0.00301	CcSEcCtD
Nicardipine—Body temperature increased—Thiotepa—sarcoma	0.00038	0.00301	CcSEcCtD
Nicardipine—Abdominal pain—Thiotepa—sarcoma	0.00038	0.00301	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000378	0.00299	CcSEcCtD
Nicardipine—Body temperature increased—Dactinomycin—sarcoma	0.000377	0.00299	CcSEcCtD
Nicardipine—Abdominal pain—Dactinomycin—sarcoma	0.000377	0.00299	CcSEcCtD
Nicardipine—Paraesthesia—Mitoxantrone—sarcoma	0.000373	0.00295	CcSEcCtD
Nicardipine—Loss of consciousness—Etoposide—sarcoma	0.000372	0.00294	CcSEcCtD
Nicardipine—Dyspnoea—Mitoxantrone—sarcoma	0.00037	0.00293	CcSEcCtD
Nicardipine—Somnolence—Mitoxantrone—sarcoma	0.000369	0.00292	CcSEcCtD
Nicardipine—CYP2B6—lymphoid tissue—sarcoma	0.000368	0.00476	CbGeAlD
Nicardipine—Dyspepsia—Mitoxantrone—sarcoma	0.000366	0.00289	CcSEcCtD
Nicardipine—Hypertension—Etoposide—sarcoma	0.000365	0.00289	CcSEcCtD
Nicardipine—CALM2—liver—sarcoma	0.000365	0.00471	CbGeAlD
Nicardipine—Pain—Vincristine—sarcoma	0.000365	0.00289	CcSEcCtD
Nicardipine—Constipation—Vincristine—sarcoma	0.000365	0.00289	CcSEcCtD
Nicardipine—CALM1—liver—sarcoma	0.000363	0.00469	CbGeAlD
Nicardipine—Chest pain—Etoposide—sarcoma	0.00036	0.00285	CcSEcCtD
Nicardipine—Orthostatic hypotension—Epirubicin—sarcoma	0.00036	0.00285	CcSEcCtD
Nicardipine—Hypokalaemia—Epirubicin—sarcoma	0.000359	0.00284	CcSEcCtD
Nicardipine—CALM3—lymph node—sarcoma	0.000356	0.0046	CbGeAlD
Nicardipine—Discomfort—Etoposide—sarcoma	0.000356	0.00282	CcSEcCtD
Nicardipine—Constipation—Mitoxantrone—sarcoma	0.000355	0.00281	CcSEcCtD
Nicardipine—Pain—Mitoxantrone—sarcoma	0.000355	0.00281	CcSEcCtD
Nicardipine—Hypersensitivity—Thiotepa—sarcoma	0.000354	0.0028	CcSEcCtD
Nicardipine—Face oedema—Doxorubicin—sarcoma	0.000352	0.00278	CcSEcCtD
Nicardipine—Hypersensitivity—Dactinomycin—sarcoma	0.000352	0.00278	CcSEcCtD
Nicardipine—Gastrointestinal pain—Vincristine—sarcoma	0.000349	0.00276	CcSEcCtD
Nicardipine—Confusional state—Etoposide—sarcoma	0.000348	0.00276	CcSEcCtD
Nicardipine—CYP2C19—liver—sarcoma	0.000346	0.00448	CbGeAlD
Nicardipine—CYP2E1—lymphoid tissue—sarcoma	0.000346	0.00447	CbGeAlD
Nicardipine—Asthenia—Thiotepa—sarcoma	0.000345	0.00273	CcSEcCtD
Nicardipine—Infection—Etoposide—sarcoma	0.000343	0.00272	CcSEcCtD
Nicardipine—Asthenia—Dactinomycin—sarcoma	0.000342	0.00271	CcSEcCtD
Nicardipine—Feeling abnormal—Mitoxantrone—sarcoma	0.000342	0.00271	CcSEcCtD
Nicardipine—ADRA1A—liver—sarcoma	0.000342	0.00442	CbGeAlD
Nicardipine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00034	0.00269	CcSEcCtD
Nicardipine—Thrombocytopenia—Etoposide—sarcoma	0.000338	0.00268	CcSEcCtD
Nicardipine—Tachycardia—Etoposide—sarcoma	0.000337	0.00267	CcSEcCtD
Nicardipine—Body temperature increased—Vincristine—sarcoma	0.000337	0.00267	CcSEcCtD
Nicardipine—Abdominal pain—Vincristine—sarcoma	0.000337	0.00267	CcSEcCtD
Nicardipine—Hyperhidrosis—Etoposide—sarcoma	0.000334	0.00264	CcSEcCtD
Nicardipine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000333	0.00263	CcSEcCtD
Nicardipine—Hypokalaemia—Doxorubicin—sarcoma	0.000332	0.00263	CcSEcCtD
Nicardipine—Angina pectoris—Epirubicin—sarcoma	0.000332	0.00262	CcSEcCtD
Nicardipine—Diarrhoea—Thiotepa—sarcoma	0.000329	0.0026	CcSEcCtD
Nicardipine—Abdominal pain—Mitoxantrone—sarcoma	0.000328	0.0026	CcSEcCtD
Nicardipine—Body temperature increased—Mitoxantrone—sarcoma	0.000328	0.0026	CcSEcCtD
Nicardipine—Diarrhoea—Dactinomycin—sarcoma	0.000327	0.00258	CcSEcCtD
Nicardipine—ABCB1—myometrium—sarcoma	0.000326	0.00421	CbGeAlD
Nicardipine—CYP2E1—tendon—sarcoma	0.000325	0.0042	CbGeAlD
Nicardipine—Hypotension—Etoposide—sarcoma	0.000323	0.00255	CcSEcCtD
Nicardipine—CYP2C8—testis—sarcoma	0.00032	0.00413	CbGeAlD
Nicardipine—Dizziness—Thiotepa—sarcoma	0.000318	0.00252	CcSEcCtD
Nicardipine—Pollakiuria—Epirubicin—sarcoma	0.000315	0.00249	CcSEcCtD
Nicardipine—Hypersensitivity—Vincristine—sarcoma	0.000314	0.00249	CcSEcCtD
Nicardipine—ABCB1—embryo—sarcoma	0.000313	0.00405	CbGeAlD
Nicardipine—Paraesthesia—Etoposide—sarcoma	0.00031	0.00245	CcSEcCtD
Nicardipine—Dyspnoea—Etoposide—sarcoma	0.000308	0.00244	CcSEcCtD
Nicardipine—Somnolence—Etoposide—sarcoma	0.000307	0.00243	CcSEcCtD
Nicardipine—Angina pectoris—Doxorubicin—sarcoma	0.000307	0.00243	CcSEcCtD
Nicardipine—Hypersensitivity—Mitoxantrone—sarcoma	0.000306	0.00242	CcSEcCtD
Nicardipine—Asthenia—Vincristine—sarcoma	0.000306	0.00242	CcSEcCtD
Nicardipine—Vomiting—Thiotepa—sarcoma	0.000306	0.00242	CcSEcCtD
Nicardipine—Vomiting—Dactinomycin—sarcoma	0.000303	0.0024	CcSEcCtD
Nicardipine—Rash—Thiotepa—sarcoma	0.000303	0.0024	CcSEcCtD
Nicardipine—Dermatitis—Thiotepa—sarcoma	0.000303	0.0024	CcSEcCtD
Nicardipine—CYP2C8—liver—sarcoma	0.000302	0.00391	CbGeAlD
Nicardipine—Headache—Thiotepa—sarcoma	0.000301	0.00238	CcSEcCtD
Nicardipine—Rash—Dactinomycin—sarcoma	0.000301	0.00238	CcSEcCtD
Nicardipine—Asthenia—Mitoxantrone—sarcoma	0.000298	0.00236	CcSEcCtD
Nicardipine—Constipation—Etoposide—sarcoma	0.000295	0.00234	CcSEcCtD
Nicardipine—Pain—Etoposide—sarcoma	0.000295	0.00234	CcSEcCtD
Nicardipine—Conjunctivitis—Epirubicin—sarcoma	0.000295	0.00234	CcSEcCtD
Nicardipine—ABCB1—seminal vesicle—sarcoma	0.000294	0.0038	CbGeAlD
Nicardipine—Diarrhoea—Vincristine—sarcoma	0.000292	0.00231	CcSEcCtD
Nicardipine—Sweating—Epirubicin—sarcoma	0.000291	0.0023	CcSEcCtD
Nicardipine—Pollakiuria—Doxorubicin—sarcoma	0.000291	0.0023	CcSEcCtD
Nicardipine—Haematuria—Epirubicin—sarcoma	0.000289	0.00229	CcSEcCtD
Nicardipine—CYP2B6—testis—sarcoma	0.000287	0.00371	CbGeAlD
Nicardipine—Nausea—Thiotepa—sarcoma	0.000286	0.00226	CcSEcCtD
Nicardipine—Sinusitis—Epirubicin—sarcoma	0.000285	0.00225	CcSEcCtD
Nicardipine—Feeling abnormal—Etoposide—sarcoma	0.000285	0.00225	CcSEcCtD
Nicardipine—Diarrhoea—Mitoxantrone—sarcoma	0.000284	0.00225	CcSEcCtD
Nicardipine—Nausea—Dactinomycin—sarcoma	0.000283	0.00224	CcSEcCtD
Nicardipine—Gastrointestinal pain—Etoposide—sarcoma	0.000282	0.00224	CcSEcCtD
Nicardipine—Dizziness—Vincristine—sarcoma	0.000282	0.00223	CcSEcCtD
Nicardipine—ABCB1—hematopoietic system—sarcoma	0.00028	0.00362	CbGeAlD
Nicardipine—CALM2—lymph node—sarcoma	0.00028	0.00361	CbGeAlD
Nicardipine—CALM1—lymph node—sarcoma	0.000278	0.0036	CbGeAlD
Nicardipine—Rhinitis—Epirubicin—sarcoma	0.000273	0.00216	CcSEcCtD
Nicardipine—Abdominal pain—Etoposide—sarcoma	0.000273	0.00216	CcSEcCtD
Nicardipine—Body temperature increased—Etoposide—sarcoma	0.000273	0.00216	CcSEcCtD
Nicardipine—Conjunctivitis—Doxorubicin—sarcoma	0.000273	0.00216	CcSEcCtD
Nicardipine—CYP3A5—liver—sarcoma	0.000273	0.00353	CbGeAlD
Nicardipine—Hypoaesthesia—Epirubicin—sarcoma	0.000271	0.00215	CcSEcCtD
Nicardipine—CYP2B6—liver—sarcoma	0.000271	0.0035	CbGeAlD
Nicardipine—Vomiting—Vincristine—sarcoma	0.000271	0.00215	CcSEcCtD
Nicardipine—Sweating—Doxorubicin—sarcoma	0.000269	0.00213	CcSEcCtD
Nicardipine—CYP2E1—testis—sarcoma	0.000269	0.00348	CbGeAlD
Nicardipine—Rash—Vincristine—sarcoma	0.000269	0.00213	CcSEcCtD
Nicardipine—Dermatitis—Vincristine—sarcoma	0.000269	0.00213	CcSEcCtD
Nicardipine—CYP2C9—liver—sarcoma	0.000268	0.00347	CbGeAlD
Nicardipine—Oedema peripheral—Epirubicin—sarcoma	0.000268	0.00212	CcSEcCtD
Nicardipine—Haematuria—Doxorubicin—sarcoma	0.000268	0.00212	CcSEcCtD
Nicardipine—Headache—Vincristine—sarcoma	0.000267	0.00211	CcSEcCtD
Nicardipine—Vomiting—Mitoxantrone—sarcoma	0.000264	0.00209	CcSEcCtD
Nicardipine—Sinusitis—Doxorubicin—sarcoma	0.000264	0.00209	CcSEcCtD
Nicardipine—Visual impairment—Epirubicin—sarcoma	0.000263	0.00208	CcSEcCtD
Nicardipine—Rash—Mitoxantrone—sarcoma	0.000262	0.00207	CcSEcCtD
Nicardipine—Dermatitis—Mitoxantrone—sarcoma	0.000262	0.00207	CcSEcCtD
Nicardipine—Headache—Mitoxantrone—sarcoma	0.00026	0.00206	CcSEcCtD
Nicardipine—Hypersensitivity—Etoposide—sarcoma	0.000254	0.00201	CcSEcCtD
Nicardipine—CYP2E1—liver—sarcoma	0.000254	0.00329	CbGeAlD
Nicardipine—Tinnitus—Epirubicin—sarcoma	0.000254	0.00201	CcSEcCtD
Nicardipine—Nausea—Vincristine—sarcoma	0.000253	0.002	CcSEcCtD
Nicardipine—Flushing—Epirubicin—sarcoma	0.000253	0.002	CcSEcCtD
Nicardipine—Rhinitis—Doxorubicin—sarcoma	0.000253	0.002	CcSEcCtD
Nicardipine—Hypoaesthesia—Doxorubicin—sarcoma	0.000251	0.00199	CcSEcCtD
Nicardipine—Oedema peripheral—Doxorubicin—sarcoma	0.000248	0.00197	CcSEcCtD
Nicardipine—Asthenia—Etoposide—sarcoma	0.000248	0.00196	CcSEcCtD
Nicardipine—Nausea—Mitoxantrone—sarcoma	0.000247	0.00195	CcSEcCtD
Nicardipine—Visual impairment—Doxorubicin—sarcoma	0.000243	0.00192	CcSEcCtD
Nicardipine—Diarrhoea—Etoposide—sarcoma	0.000236	0.00187	CcSEcCtD
Nicardipine—Tinnitus—Doxorubicin—sarcoma	0.000235	0.00186	CcSEcCtD
Nicardipine—Flushing—Doxorubicin—sarcoma	0.000234	0.00185	CcSEcCtD
Nicardipine—Tension—Epirubicin—sarcoma	0.000233	0.00184	CcSEcCtD
Nicardipine—Nervousness—Epirubicin—sarcoma	0.00023	0.00182	CcSEcCtD
Nicardipine—Dizziness—Etoposide—sarcoma	0.000228	0.00181	CcSEcCtD
Nicardipine—Vision blurred—Epirubicin—sarcoma	0.000224	0.00177	CcSEcCtD
Nicardipine—Ill-defined disorder—Epirubicin—sarcoma	0.00022	0.00174	CcSEcCtD
Nicardipine—Vomiting—Etoposide—sarcoma	0.00022	0.00174	CcSEcCtD
Nicardipine—Agitation—Epirubicin—sarcoma	0.000218	0.00173	CcSEcCtD
Nicardipine—Rash—Etoposide—sarcoma	0.000218	0.00172	CcSEcCtD
Nicardipine—Dermatitis—Etoposide—sarcoma	0.000218	0.00172	CcSEcCtD
Nicardipine—Headache—Etoposide—sarcoma	0.000216	0.00171	CcSEcCtD
Nicardipine—Tension—Doxorubicin—sarcoma	0.000215	0.0017	CcSEcCtD
Nicardipine—Malaise—Epirubicin—sarcoma	0.000214	0.00169	CcSEcCtD
Nicardipine—Nervousness—Doxorubicin—sarcoma	0.000213	0.00169	CcSEcCtD
Nicardipine—Vertigo—Epirubicin—sarcoma	0.000213	0.00169	CcSEcCtD
Nicardipine—CYP2D6—testis—sarcoma	0.000213	0.00275	CbGeAlD
Nicardipine—Syncope—Epirubicin—sarcoma	0.000213	0.00168	CcSEcCtD
Nicardipine—ABCB1—uterus—sarcoma	0.000211	0.00273	CbGeAlD
Nicardipine—Palpitations—Epirubicin—sarcoma	0.00021	0.00166	CcSEcCtD
Nicardipine—Loss of consciousness—Epirubicin—sarcoma	0.000209	0.00165	CcSEcCtD
Nicardipine—Vision blurred—Doxorubicin—sarcoma	0.000207	0.00164	CcSEcCtD
Nicardipine—Nausea—Etoposide—sarcoma	0.000205	0.00162	CcSEcCtD
Nicardipine—Hypertension—Epirubicin—sarcoma	0.000205	0.00162	CcSEcCtD
Nicardipine—CYP3A4—liver—sarcoma	0.000205	0.00265	CbGeAlD
Nicardipine—Ill-defined disorder—Doxorubicin—sarcoma	0.000204	0.00161	CcSEcCtD
Nicardipine—Arthralgia—Epirubicin—sarcoma	0.000202	0.0016	CcSEcCtD
Nicardipine—Myalgia—Epirubicin—sarcoma	0.000202	0.0016	CcSEcCtD
Nicardipine—Chest pain—Epirubicin—sarcoma	0.000202	0.0016	CcSEcCtD
Nicardipine—Agitation—Doxorubicin—sarcoma	0.000202	0.0016	CcSEcCtD
Nicardipine—CYP2D6—liver—sarcoma	0.000201	0.0026	CbGeAlD
Nicardipine—Anxiety—Epirubicin—sarcoma	0.000201	0.00159	CcSEcCtD
Nicardipine—Discomfort—Epirubicin—sarcoma	0.0002	0.00158	CcSEcCtD
Nicardipine—Malaise—Doxorubicin—sarcoma	0.000198	0.00157	CcSEcCtD
Nicardipine—Dry mouth—Epirubicin—sarcoma	0.000198	0.00156	CcSEcCtD
Nicardipine—Vertigo—Doxorubicin—sarcoma	0.000197	0.00156	CcSEcCtD
Nicardipine—ABCB1—lymphoid tissue—sarcoma	0.000197	0.00255	CbGeAlD
Nicardipine—Syncope—Doxorubicin—sarcoma	0.000197	0.00156	CcSEcCtD
Nicardipine—Confusional state—Epirubicin—sarcoma	0.000195	0.00154	CcSEcCtD
Nicardipine—Palpitations—Doxorubicin—sarcoma	0.000194	0.00154	CcSEcCtD
Nicardipine—Oedema—Epirubicin—sarcoma	0.000194	0.00153	CcSEcCtD
Nicardipine—Loss of consciousness—Doxorubicin—sarcoma	0.000193	0.00153	CcSEcCtD
Nicardipine—Infection—Epirubicin—sarcoma	0.000192	0.00152	CcSEcCtD
Nicardipine—Shock—Epirubicin—sarcoma	0.00019	0.00151	CcSEcCtD
Nicardipine—Thrombocytopenia—Epirubicin—sarcoma	0.00019	0.0015	CcSEcCtD
Nicardipine—Hypertension—Doxorubicin—sarcoma	0.00019	0.0015	CcSEcCtD
Nicardipine—Tachycardia—Epirubicin—sarcoma	0.000189	0.0015	CcSEcCtD
Nicardipine—Hyperhidrosis—Epirubicin—sarcoma	0.000187	0.00148	CcSEcCtD
Nicardipine—Chest pain—Doxorubicin—sarcoma	0.000187	0.00148	CcSEcCtD
Nicardipine—Myalgia—Doxorubicin—sarcoma	0.000187	0.00148	CcSEcCtD
Nicardipine—Arthralgia—Doxorubicin—sarcoma	0.000187	0.00148	CcSEcCtD
Nicardipine—Anxiety—Doxorubicin—sarcoma	0.000186	0.00147	CcSEcCtD
Nicardipine—Discomfort—Doxorubicin—sarcoma	0.000185	0.00146	CcSEcCtD
Nicardipine—Dry mouth—Doxorubicin—sarcoma	0.000183	0.00145	CcSEcCtD
Nicardipine—Hypotension—Epirubicin—sarcoma	0.000181	0.00143	CcSEcCtD
Nicardipine—Confusional state—Doxorubicin—sarcoma	0.000181	0.00143	CcSEcCtD
Nicardipine—ABCB1—bone marrow—sarcoma	0.000179	0.00232	CbGeAlD
Nicardipine—Oedema—Doxorubicin—sarcoma	0.000179	0.00142	CcSEcCtD
Nicardipine—Infection—Doxorubicin—sarcoma	0.000178	0.00141	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000176	0.0014	CcSEcCtD
Nicardipine—Shock—Doxorubicin—sarcoma	0.000176	0.00139	CcSEcCtD
Nicardipine—Thrombocytopenia—Doxorubicin—sarcoma	0.000175	0.00139	CcSEcCtD
Nicardipine—Insomnia—Epirubicin—sarcoma	0.000175	0.00139	CcSEcCtD
Nicardipine—Tachycardia—Doxorubicin—sarcoma	0.000175	0.00138	CcSEcCtD
Nicardipine—Paraesthesia—Epirubicin—sarcoma	0.000174	0.00138	CcSEcCtD
Nicardipine—Hyperhidrosis—Doxorubicin—sarcoma	0.000173	0.00137	CcSEcCtD
Nicardipine—Dyspnoea—Epirubicin—sarcoma	0.000173	0.00137	CcSEcCtD
Nicardipine—Somnolence—Epirubicin—sarcoma	0.000172	0.00136	CcSEcCtD
Nicardipine—Dyspepsia—Epirubicin—sarcoma	0.00017	0.00135	CcSEcCtD
Nicardipine—Hypotension—Doxorubicin—sarcoma	0.000167	0.00132	CcSEcCtD
Nicardipine—Constipation—Epirubicin—sarcoma	0.000166	0.00131	CcSEcCtD
Nicardipine—Pain—Epirubicin—sarcoma	0.000166	0.00131	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000163	0.00129	CcSEcCtD
Nicardipine—Insomnia—Doxorubicin—sarcoma	0.000162	0.00128	CcSEcCtD
Nicardipine—Paraesthesia—Doxorubicin—sarcoma	0.000161	0.00127	CcSEcCtD
Nicardipine—Dyspnoea—Doxorubicin—sarcoma	0.00016	0.00126	CcSEcCtD
Nicardipine—Feeling abnormal—Epirubicin—sarcoma	0.00016	0.00126	CcSEcCtD
Nicardipine—Somnolence—Doxorubicin—sarcoma	0.000159	0.00126	CcSEcCtD
Nicardipine—Gastrointestinal pain—Epirubicin—sarcoma	0.000158	0.00125	CcSEcCtD
Nicardipine—Dyspepsia—Doxorubicin—sarcoma	0.000158	0.00125	CcSEcCtD
Nicardipine—ABCB1—testis—sarcoma	0.000153	0.00198	CbGeAlD
Nicardipine—Pain—Doxorubicin—sarcoma	0.000153	0.00121	CcSEcCtD
Nicardipine—Constipation—Doxorubicin—sarcoma	0.000153	0.00121	CcSEcCtD
Nicardipine—Abdominal pain—Epirubicin—sarcoma	0.000153	0.00121	CcSEcCtD
Nicardipine—Body temperature increased—Epirubicin—sarcoma	0.000153	0.00121	CcSEcCtD
Nicardipine—Feeling abnormal—Doxorubicin—sarcoma	0.000148	0.00117	CcSEcCtD
Nicardipine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000146	0.00116	CcSEcCtD
Nicardipine—ABCB1—liver—sarcoma	0.000145	0.00187	CbGeAlD
Nicardipine—Hypersensitivity—Epirubicin—sarcoma	0.000143	0.00113	CcSEcCtD
Nicardipine—Abdominal pain—Doxorubicin—sarcoma	0.000142	0.00112	CcSEcCtD
Nicardipine—Body temperature increased—Doxorubicin—sarcoma	0.000142	0.00112	CcSEcCtD
Nicardipine—Asthenia—Epirubicin—sarcoma	0.000139	0.0011	CcSEcCtD
Nicardipine—Diarrhoea—Epirubicin—sarcoma	0.000132	0.00105	CcSEcCtD
Nicardipine—Hypersensitivity—Doxorubicin—sarcoma	0.000132	0.00104	CcSEcCtD
Nicardipine—Asthenia—Doxorubicin—sarcoma	0.000129	0.00102	CcSEcCtD
Nicardipine—Dizziness—Epirubicin—sarcoma	0.000128	0.00101	CcSEcCtD
Nicardipine—Vomiting—Epirubicin—sarcoma	0.000123	0.000974	CcSEcCtD
Nicardipine—Diarrhoea—Doxorubicin—sarcoma	0.000123	0.00097	CcSEcCtD
Nicardipine—Rash—Epirubicin—sarcoma	0.000122	0.000966	CcSEcCtD
Nicardipine—Dermatitis—Epirubicin—sarcoma	0.000122	0.000965	CcSEcCtD
Nicardipine—Headache—Epirubicin—sarcoma	0.000121	0.00096	CcSEcCtD
Nicardipine—Dizziness—Doxorubicin—sarcoma	0.000118	0.000937	CcSEcCtD
Nicardipine—Nausea—Epirubicin—sarcoma	0.000115	0.00091	CcSEcCtD
Nicardipine—Vomiting—Doxorubicin—sarcoma	0.000114	0.000901	CcSEcCtD
Nicardipine—Rash—Doxorubicin—sarcoma	0.000113	0.000894	CcSEcCtD
Nicardipine—Dermatitis—Doxorubicin—sarcoma	0.000113	0.000893	CcSEcCtD
Nicardipine—Headache—Doxorubicin—sarcoma	0.000112	0.000888	CcSEcCtD
Nicardipine—ABCB1—lymph node—sarcoma	0.000111	0.00144	CbGeAlD
Nicardipine—Nausea—Doxorubicin—sarcoma	0.000106	0.000842	CcSEcCtD
Nicardipine—ADRA1B—Signaling by GPCR—EGFR—sarcoma	1.07e-05	4.99e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—HBA1—sarcoma	1.07e-05	4.99e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—CTNNB1—sarcoma	1.07e-05	4.98e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KIT—sarcoma	1.06e-05	4.94e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—NRAS—sarcoma	1.06e-05	4.94e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL2—sarcoma	1.06e-05	4.94e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KIT—sarcoma	1.06e-05	4.92e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—NRAS—sarcoma	1.06e-05	4.92e-05	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—HRAS—sarcoma	1.06e-05	4.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL2—sarcoma	1.06e-05	4.91e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KIT—sarcoma	1.05e-05	4.88e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—NRAS—sarcoma	1.05e-05	4.88e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KIT—sarcoma	1.05e-05	4.86e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—NRAS—sarcoma	1.05e-05	4.86e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—MDM2—sarcoma	1.04e-05	4.86e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—MDM2—sarcoma	1.04e-05	4.86e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—HRAS—sarcoma	1.04e-05	4.83e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CCND1—sarcoma	1.03e-05	4.81e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—JUN—sarcoma	1.03e-05	4.8e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—CTNNB1—sarcoma	1.02e-05	4.77e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL2—sarcoma	1.02e-05	4.75e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—IL2—sarcoma	1.02e-05	4.75e-05	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—HRAS—sarcoma	1.02e-05	4.73e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—KRAS—sarcoma	1.01e-05	4.71e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CREB1—sarcoma	1.01e-05	4.7e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—sarcoma	1.01e-05	4.7e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CREB1—sarcoma	1.01e-05	4.69e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—IL2—sarcoma	9.98e-06	4.64e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CREB1—sarcoma	9.98e-06	4.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MDM2—sarcoma	9.97e-06	4.64e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CREB1—sarcoma	9.95e-06	4.63e-05	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—HRAS—sarcoma	9.84e-06	4.58e-05	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—HRAS—sarcoma	9.84e-06	4.58e-05	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—HRAS—sarcoma	9.77e-06	4.54e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CCND1—sarcoma	9.73e-06	4.52e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—JUN—sarcoma	9.71e-06	4.52e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—EGFR—sarcoma	9.68e-06	4.5e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—SRC—sarcoma	9.67e-06	4.5e-05	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—HRAS—sarcoma	9.66e-06	4.49e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL2—sarcoma	9.65e-06	4.49e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—EGFR—sarcoma	9.64e-06	4.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MDM2—sarcoma	9.64e-06	4.48e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MDM2—sarcoma	9.64e-06	4.48e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—CTNNB1—sarcoma	9.63e-06	4.48e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KDR—sarcoma	9.62e-06	4.47e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—EGFR—sarcoma	9.55e-06	4.44e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—EGFR—sarcoma	9.52e-06	4.43e-05	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—HRAS—sarcoma	9.45e-06	4.39e-05	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—HRAS—sarcoma	9.45e-06	4.39e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—VEGFA—sarcoma	9.42e-06	4.38e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—JUN—sarcoma	9.38e-06	4.36e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL2—sarcoma	9.33e-06	4.34e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL2—sarcoma	9.33e-06	4.34e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—CTNNB1—sarcoma	9.31e-06	4.33e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KDR—sarcoma	9.31e-06	4.33e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KDR—sarcoma	9.31e-06	4.33e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—NRAS—sarcoma	9.3e-06	4.33e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MDM2—sarcoma	9.27e-06	4.31e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—SRC—sarcoma	9.26e-06	4.31e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PLCG1—sarcoma	9.15e-06	4.26e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—KRAS—sarcoma	9.14e-06	4.25e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—KRAS—sarcoma	9.11e-06	4.24e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—JUN—sarcoma	9.08e-06	4.22e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—JUN—sarcoma	9.08e-06	4.22e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—KRAS—sarcoma	9.02e-06	4.2e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—VEGFA—sarcoma	9.02e-06	4.2e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—CTNNB1—sarcoma	9.01e-06	4.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—CTNNB1—sarcoma	9.01e-06	4.19e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—KRAS—sarcoma	9e-06	4.19e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—NRAS—sarcoma	8.91e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KIT—sarcoma	8.86e-06	4.12e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—NRAS—sarcoma	8.86e-06	4.12e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—SRC—sarcoma	8.71e-06	4.05e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MYC—sarcoma	8.67e-06	4.03e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—HRAS—sarcoma	8.61e-06	4e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—CTNNB1—sarcoma	8.6e-06	4e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KIT—sarcoma	8.57e-06	3.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KIT—sarcoma	8.57e-06	3.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—NRAS—sarcoma	8.57e-06	3.99e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—NRAS—sarcoma	8.57e-06	3.99e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—VEGFA—sarcoma	8.48e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EGFR—sarcoma	8.48e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CREB1—sarcoma	8.44e-06	3.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—SRC—sarcoma	8.42e-06	3.92e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—NRAS—sarcoma	8.38e-06	3.9e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MDM2—sarcoma	8.36e-06	3.89e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MDM2—sarcoma	8.34e-06	3.88e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—CTNNB1—sarcoma	8.32e-06	3.87e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—CTNNB1—sarcoma	8.32e-06	3.87e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MYC—sarcoma	8.3e-06	3.86e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—IL2—sarcoma	8.28e-06	3.85e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MDM2—sarcoma	8.26e-06	3.84e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MDM2—sarcoma	8.23e-06	3.83e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CREB1—sarcoma	8.16e-06	3.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CREB1—sarcoma	8.16e-06	3.8e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—SRC—sarcoma	8.14e-06	3.79e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—SRC—sarcoma	8.14e-06	3.79e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—sarcoma	8.12e-06	3.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—NRAS—sarcoma	8.1e-06	3.77e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—sarcoma	8.07e-06	3.76e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CCND1—sarcoma	8.07e-06	3.76e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—JUN—sarcoma	8.06e-06	3.75e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—KRAS—sarcoma	8.01e-06	3.72e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—CTNNB1—sarcoma	8e-06	3.72e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—NRAS—sarcoma	7.83e-06	3.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—NRAS—sarcoma	7.83e-06	3.64e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—sarcoma	7.81e-06	3.63e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—sarcoma	7.81e-06	3.63e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—MYC—sarcoma	7.8e-06	3.63e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—SRC—sarcoma	7.77e-06	3.61e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—HRAS—sarcoma	7.77e-06	3.61e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—HRAS—sarcoma	7.74e-06	3.6e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—HRAS—sarcoma	7.67e-06	3.57e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KRAS—sarcoma	7.67e-06	3.57e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—HRAS—sarcoma	7.65e-06	3.56e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—sarcoma	7.63e-06	3.55e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—KRAS—sarcoma	7.63e-06	3.55e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—SRC—sarcoma	7.52e-06	3.5e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—SRC—sarcoma	7.52e-06	3.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—NRAS—sarcoma	7.48e-06	3.48e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—IL2—sarcoma	7.47e-06	3.48e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL2—sarcoma	7.45e-06	3.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—KRAS—sarcoma	7.38e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—KRAS—sarcoma	7.38e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—sarcoma	7.38e-06	3.43e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL2—sarcoma	7.38e-06	3.43e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL2—sarcoma	7.36e-06	3.42e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCND1—sarcoma	7.28e-06	3.39e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—JUN—sarcoma	7.27e-06	3.38e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCND1—sarcoma	7.26e-06	3.38e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—JUN—sarcoma	7.25e-06	3.37e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—NRAS—sarcoma	7.23e-06	3.36e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—NRAS—sarcoma	7.23e-06	3.36e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—SRC—sarcoma	7.23e-06	3.36e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CTNNB1—sarcoma	7.21e-06	3.36e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KRAS—sarcoma	7.21e-06	3.35e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCND1—sarcoma	7.19e-06	3.34e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CTNNB1—sarcoma	7.19e-06	3.34e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—JUN—sarcoma	7.18e-06	3.34e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCND1—sarcoma	7.17e-06	3.34e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—JUN—sarcoma	7.16e-06	3.33e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—sarcoma	7.14e-06	3.32e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—sarcoma	7.14e-06	3.32e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CTNNB1—sarcoma	7.12e-06	3.31e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—sarcoma	7.12e-06	3.31e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	7.1e-06	3.3e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—sarcoma	7.04e-06	3.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MDM2—sarcoma	6.98e-06	3.25e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KRAS—sarcoma	6.97e-06	3.24e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—sarcoma	6.96e-06	3.24e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NRAS—sarcoma	6.95e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—sarcoma	6.82e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—sarcoma	6.81e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—sarcoma	6.81e-06	3.17e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MDM2—sarcoma	6.75e-06	3.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MDM2—sarcoma	6.75e-06	3.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—sarcoma	6.74e-06	3.14e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—sarcoma	6.74e-06	3.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—sarcoma	6.74e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—sarcoma	6.74e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—sarcoma	6.59e-06	3.06e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—sarcoma	6.59e-06	3.06e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—sarcoma	6.52e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—sarcoma	6.52e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—sarcoma	6.5e-06	3.02e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—sarcoma	6.48e-06	3.02e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—sarcoma	6.48e-06	3.01e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—sarcoma	6.44e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—sarcoma	6.43e-06	2.99e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—sarcoma	6.42e-06	2.99e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—sarcoma	6.41e-06	2.98e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—sarcoma	6.35e-06	2.95e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—sarcoma	6.33e-06	2.95e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—sarcoma	6.33e-06	2.94e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—sarcoma	6.27e-06	2.92e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—sarcoma	6.27e-06	2.92e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—sarcoma	6.27e-06	2.92e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—sarcoma	6.27e-06	2.92e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—sarcoma	6.25e-06	2.91e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—sarcoma	6.25e-06	2.91e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL2—sarcoma	6.24e-06	2.9e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—sarcoma	6.22e-06	2.9e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—sarcoma	6.22e-06	2.9e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—sarcoma	6.19e-06	2.88e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—sarcoma	6.18e-06	2.87e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—sarcoma	6.13e-06	2.85e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—sarcoma	6.08e-06	2.83e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—JUN—sarcoma	6.07e-06	2.82e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL2—sarcoma	6.03e-06	2.81e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL2—sarcoma	6.03e-06	2.81e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—sarcoma	6.02e-06	2.8e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—sarcoma	5.98e-06	2.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—sarcoma	5.92e-06	2.76e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—sarcoma	5.88e-06	2.74e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—sarcoma	5.88e-06	2.74e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—JUN—sarcoma	5.87e-06	2.73e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—JUN—sarcoma	5.87e-06	2.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—sarcoma	5.84e-06	2.72e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—sarcoma	5.82e-06	2.71e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—sarcoma	5.82e-06	2.71e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—sarcoma	5.82e-06	2.71e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—sarcoma	5.77e-06	2.68e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—sarcoma	5.75e-06	2.68e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—sarcoma	5.73e-06	2.67e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—sarcoma	5.73e-06	2.67e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—sarcoma	5.72e-06	2.66e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—sarcoma	5.7e-06	2.65e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—sarcoma	5.64e-06	2.62e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—sarcoma	5.63e-06	2.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—sarcoma	5.47e-06	2.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—sarcoma	5.44e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—sarcoma	5.4e-06	2.51e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—sarcoma	5.38e-06	2.5e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—sarcoma	5.33e-06	2.48e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—sarcoma	5.32e-06	2.47e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—sarcoma	5.32e-06	2.47e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—sarcoma	5.3e-06	2.47e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—sarcoma	5.29e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—sarcoma	5.29e-06	2.46e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—sarcoma	5.26e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—sarcoma	5.26e-06	2.45e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—sarcoma	5.24e-06	2.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—sarcoma	5.13e-06	2.38e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—sarcoma	5.13e-06	2.38e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—sarcoma	5.09e-06	2.37e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—sarcoma	5.06e-06	2.36e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—sarcoma	5.06e-06	2.36e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—sarcoma	4.88e-06	2.27e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—sarcoma	4.8e-06	2.23e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—sarcoma	4.78e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—sarcoma	4.77e-06	2.22e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—sarcoma	4.74e-06	2.2e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—sarcoma	4.72e-06	2.2e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—sarcoma	4.72e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—sarcoma	4.72e-06	2.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—sarcoma	4.61e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—sarcoma	4.61e-06	2.15e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—sarcoma	4.59e-06	2.13e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—sarcoma	4.57e-06	2.13e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—sarcoma	4.53e-06	2.11e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—sarcoma	4.52e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—sarcoma	4.51e-06	2.1e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—sarcoma	4.36e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—sarcoma	4.36e-06	2.03e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—sarcoma	4e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—sarcoma	3.87e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—sarcoma	3.87e-06	1.8e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—sarcoma	3.83e-06	1.78e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—sarcoma	3.71e-06	1.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—sarcoma	3.71e-06	1.72e-05	CbGpPWpGaD
